Search research articles
Contact Us
Filters
Showing results (491-500 of 499) with videos related to
Page
of 50
Sort By:
You have reached the last page of results.
This site can display upto 499 results.
Molecular Cancer Therapeutics
|
March 13, 2023
Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners
Aatman S Doshi, Susan Cantin, Marylens Hernandez, et al.
Cell
|
May 20, 2020
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells
Yunlong Cao, Bin Su, Xianghua Guo, et al.
Diabetologia
|
March 9, 2021
Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study
Linong Ji, Ying Du, Min Xu, et al.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Journal of Clinical Otorhinolaryngology Head and Neck Surgery
|
April 1, 2025
[Expert consensus on the application of nasal cavity filling substances in nasal surgery patients（2025, Shanghai）]
Keqing Zhao, Shaoqing Yu, Hongquan Wei, et al.
Cell Chemical Biology
|
April 10, 2018
Dependence on the Pyrimidine Biosynthetic Enzyme DHODH Is a Synthetic Lethal Vulnerability in Mutant KRAS-Driven Cancers
Malvika Koundinya, Judith Sudhalter, Albane Courjaud, et al.
Frontiers in Psychiatry
|
July 1, 2021
Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China
Shuang Liu, Wei Han, Chenyu Shen, et al.
BMC Medicine
|
October 9, 2023
Fotagliptin monotherapy with alogliptin as an active comparator in patients with uncontrolled type 2 diabetes mellitus: a randomized, multicenter, double-blind, placebo-controlled, phase 3 trial
Mingtong Xu, Kan Sun, Wenjie Xu, et al.
Journal of Medicinal Chemistry
|
September 3, 2025
Discovery of AZD8421: A Potent CDK2 Inhibitor with Selectivity Against Other CDK Family Members and the Human Kinome
Avipsa Ghosh, Afshan Ahmed, Konstantina Amoiradaki, et al.
Journal of Medicinal Chemistry
|
February 10, 2025
Discovery and Optimization of Pyrazine Carboxamide AZ3246, a Selective HPK1 Inhibitor
Jason D Shields, David Baker, Amber Y S Balazs, et al.
Page
of 50
Search research articles
Search
Showing results (491-500 of 499) with videos related to
Sort By:
Page
of 50
You have reached the last page of results.
This site can display upto 499 results.
Molecular Cancer Therapeutics
|
March 13, 2023
Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners
Aatman S Doshi, Susan Cantin, Marylens Hernandez, et al.
Cell
|
May 20, 2020
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells
Yunlong Cao, Bin Su, Xianghua Guo, et al.
Diabetologia
|
March 9, 2021
Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study
Linong Ji, Ying Du, Min Xu, et al.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Journal of Clinical Otorhinolaryngology Head and Neck Surgery
|
April 1, 2025
[Expert consensus on the application of nasal cavity filling substances in nasal surgery patients（2025, Shanghai）]
Keqing Zhao, Shaoqing Yu, Hongquan Wei, et al.
Cell Chemical Biology
|
April 10, 2018
Dependence on the Pyrimidine Biosynthetic Enzyme DHODH Is a Synthetic Lethal Vulnerability in Mutant KRAS-Driven Cancers
Malvika Koundinya, Judith Sudhalter, Albane Courjaud, et al.
Frontiers in Psychiatry
|
July 1, 2021
Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China
Shuang Liu, Wei Han, Chenyu Shen, et al.
BMC Medicine
|
October 9, 2023
Fotagliptin monotherapy with alogliptin as an active comparator in patients with uncontrolled type 2 diabetes mellitus: a randomized, multicenter, double-blind, placebo-controlled, phase 3 trial
Mingtong Xu, Kan Sun, Wenjie Xu, et al.
Journal of Medicinal Chemistry
|
September 3, 2025
Discovery of AZD8421: A Potent CDK2 Inhibitor with Selectivity Against Other CDK Family Members and the Human Kinome
Avipsa Ghosh, Afshan Ahmed, Konstantina Amoiradaki, et al.
Journal of Medicinal Chemistry
|
February 10, 2025
Discovery and Optimization of Pyrazine Carboxamide AZ3246, a Selective HPK1 Inhibitor
Jason D Shields, David Baker, Amber Y S Balazs, et al.
Page
of 50